Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Post-transplantation Diabetes Mellitus
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 06 Jul 2018
At a glance
- Drugs Empagliflozin (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Acronyms EMPA-RenalTx
- 31 Aug 2018 Biomarkers information updated
- 28 Jun 2018 Planned End Date changed from 1 Dec 2017 to 1 Jul 2018.
- 28 Jun 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jul 2018.